Cerebral microbleeds (CMBs) are considered to be a novel marker of cerebral small vessel disease. However, the link with cognitive impairment remains unclear. We investigated whether CMBs-independent of other traditional markers of cerebral small vessel disease-are related to cognition. Chinese subjects from the population-based Singapore Chinese Eye Study, who failed an initial cognitive screening and were recruited into the ongoing Epidemiology of Dementia in Singapore Study, underwent neuropsychological testing and 3 T brain magnetic resonance imaging. The presence and number of CMBs were graded using Brain Observer Microbleed Scale on susceptibility-weighted images. Other magnetic resonance imaging lesions that were graded included presence of lacunes, white matter lesion, and total brain volumes. A comprehensive neuropsychological battery was administered and cognitive function was summarized as composite and domain-specific Z-scores. Among 282 subjects, 91 had any CMBs (32.3%), of whom 36 (12.8%) had multiple CMBs. CMBs were-independent of cardiovascular risk factors and other markers of cerebral small vessel disease-significantly associated with poorer cognitive function as reflected by composite Z-score (mean difference per CMB increase: À0.06; 95% confidence interval: À 0.11, À0.01] and with domain-specific Z-scores including executive function, attention, and visuoconstruction. Among Chinese subjects CMBs were, independent of other concomitant markers of cerebral small vessel disease, associated with poorer cognitive function.
(Alzheimer Dis Assoc Disord 2014; 28:106-112) C erebral microbleeds (CMB) are radiologically defined lesions on magnetic resonance imaging (MRI) sequences, most commonly on gradient-echo T2* or susceptibility-weighted images (SWI), which correspond pathologically to hemosiderin deposits surrounding small vessels. 1, 2 In healthy populations the reported prevalence of CMBs ranges from 3.8% to 38.3%, whereas in patients with stroke the corresponding figures may be as high as 50% to 70%. [3] [4] [5] [6] Histopathologic studies have shown that CMBs are associated with surrounding tissue damage. 7, 8 Although a direct impact of CMBs on cognitive function has been hypothesized, results from studies have varied. [9] [10] [11] [12] CMBs are associated with both a higher amyloid burden and are also known to occur in patients with Alzheimer disease. Furthermore, previous studies showed that CMBs occur concomitantly with white matter lesions (WMLs) and lacunar stroke. [12] [13] [14] Thus, an independent effect of CMBs on cognition may be implicated only if other associated pathologies are accounted for. 15 With respect to Asian populations, studies from Japan reported that the presence of CMBs is related to a poorer cognitive function. 16, 17 However, in these studies cognitive function was assessed solely by the mini-mental status examination (MMSE), and 1.5 T MRI was utilized for assessment of CMBs. As yet, there are no data from Chinese populations on the association with cognitive impairment as assessed by an extensive neuropsychological test battery. Therefore, in the present study, we investigated the association of CMBs with cognition, as assessed by a comprehensive neuropsychological evaluation among Chinese subjects from the population-based Singapore Chinese Eye Study (SCES), who failed an initial cognitive screening and were recruited into the ongoing Epidemiology of Dementia in Singapore (EDIS) Study. Furthermore, when examining this association we took into account the presence of other MRI features, as reflected by markers of cerebral small vessel disease and neurodegeneration on MRI.
METHODS

Study Population
The ongoing EDIS study drew subjects from the population-based study among Chinese aged 40 to 85 years, who participated in the SCES. To use the limited resources in an efficient way, it was decided to focus on those subjects who were most likely to have some cognitive problems. Hence, in the first phase of the EDIS Study, Chinese participants from SCES aged 60 years and above (n = 1538) were screened using the Abbreviated Mental Test (AMT) and a self-report of progressive forgetfulness. The AMT is a brief cognitive screening instrument based on 10 questions, which has previously been validated in Singapore. 18 Optimal education-specific cutoff values were established for the detection of dementia: screen positives were defined as AMT score r6, among those with r6 years of formal education, or r8 among those with >6 years of formal education; or if the subject or caregiver reported progressive forgetfulness. Screen-positive subjects (n = 612) were invited to take part in the second phase of this study, which included an extensive neuropsychological test battery and brain MRI. Of these 612 participants, 300 agreed to participate in phase II and hence were included in the present study. Ethics approval for EDIS was obtained from the Singapore Eye Research Institute and National Healthcare group Institutional Review Boards. Informed consent was obtained for all participants before recruitment. The details of the study methodology have been described elsewhere. 19 
Neuroimaging
MRI Acquisition
MRI scans were performed on a 3 T Siemens Magnetom Trio Tim scanner using a 32-channel head coil at the Clinical Imaging Research Centre, National University of Singapore, Singapore. A number of standardized and advanced MRI brain sequences were performed including SWI sequences to detect CMBs with time-to-echo, 20 ms; repetition time, 27 ms; flip angle, 15 degrees; field of view, 256 mm; field of view phase, 75%; image matrix, 192Â 256 mm; slice thickness, 1.50 mm. Subjects with claustrophobia, contraindications for MRI, or those who were unable to tolerate the procedure were excluded.
Grading of CMB
The presence, location, and number of CMBs were graded on SWI according to the Brain Observer Micro Bleed Scale. 20 CMBs were defined as focal, rounded areas of hypointensity (T1-weighted and T2-weighted images), 2 to 10 mm in diameter with blooming on T2*-weighted scans. Symmetrical hypointensities in the basal ganglia, choroid plexus, and pineal gland caused by calcification, hypointense lesions within the subarachnoid space, or those possibly associated with traumatic brain injury, hemorrhagic infarcts or vascular malformation were carefully excluded. CMBs were categorized according to their location into cortical (cortical gray matter and gray-white matter junction), subcortical white matter (subcortical or periventricular white matter), subcortical gray matter (basal ganglia and the thalamus), and infratentorial (brain stem and cerebellum). Furthermore, lobar location was defined as cortical, subcortical, or periventricular white matter, whereas deep as subcortical gray matter, and the white matter of the corpus callosum, internal and external capsule. All scans were graded by 1 radiologist and 2 clinicians blinded to all other subjects' characteristics. Any disagreement was brought to consensus for the final decision.
Other Markers on MRI
Other MRI markers of cerebrovascular diseases and neurodegeneration were graded using the following sequences and scales:
Lacunes were defined as lesions, 3 to 20 mm in diameter, with low signal on T1-weighted image and Fluid Attenuated Inversion Recovery (FLAIR); a high signal on T2-weighted image, and a perilesional halo on FLAIR images. The interrater and intrarater reliability as expressed by k statistic ranged from 0.59 to 0.80. Total brain volume and WMLs volume were quantified by automatic segmentation at the Erasmus MC, University Medical Center, the Netherlands. Brain tissue segmentation was quantified by proton density-weighted T1 sequence and T2-weighted images, whereas the WML volume was segmented using FLAIR as described previously. [21] [22] [23] Briefly, as a marker of global atrophy, total brain volume was calculated as the sum of gray matter and white matter volumes of the 5 regions; frontal, parietal, occipital, temporal, and central regions. WML volume was the summation of the WMLs in the above-mentioned 5 regions.
Cognitive Assessment
A formal neuropsychological battery, previously validated for the Singaporean elderly, was administered to all participants. 24 The following cognitive domains, utilizing respective neuropsychological tests, were examined:
Executive Z-scores were derived for individual subtests, whereas Z-scores for individual domains were computed by summing up the Z-scores of each subtest under that domain and dividing by number of subtests. Domain-specific Z-scores were utilized to compute the final composite Zscore. The modified 15-item Geriatric Depression Scale was also administered to all subjects. 25 The diagnoses of dementia were made according to the DSM-IV criteria.
Assessment of Other Risk Factors
Demographic and vascular risk factors including age, sex, education, smoking, hypertension, diabetes, hyperlipidemia, height, weight, and history of stroke were collected and verified by medical records. 19 Blood tests included full blood count, random blood glucose, and lipids including total cholesterol. Systolic and diastolic blood pressures were measured using a digital automatic blood pressure monitor (OMRON-HEM 7203, Japan) after the subject rested for 5 minutes. Blood pressure was measured twice, 5 minutes apart. The mean of the 2 readings was considered as the relevant blood pressure. Data on medication use included use of antiplatelets or anticoagulants. Education was categorized into <primary 6 and Zprimary 6.
Smoking was categorized into ever smokers (past and current smokers) versus never smokers. Body mass index was calculated as the weight in kilogram divided by the square of height in meters.
Statistical Analysis
Baseline characteristics are presented as means ± SD or number (%), and were compared between subjects with and without CMB. w 2 test was used for categorical variables, Student t test for normally distributed continuous variables, and Mann-Whitney U test for skewed distributed continuous variable (WML).
Regarding quantitative MRI markers, WML volume was logarithmically transformed, to ensure a normal distribution. With respect to the associations between CMBs and other MRI markers: logistic regression models were constructed for lacunes, and linear regression models for WML and total brain volume. These models were adjusted initially for age and sex; subsequently for smoking, mean arterial blood pressure, cholesterol, random blood glucose and, finally, for the other MRI markers.
For the associations of CMBs with cognition, linear regression models were constructed for composite and domain-specific Z-scores. These regression models with cognition were adjusted initially for age, sex, and education; subsequently for mean arterial blood pressure, cholesterol, random blood glucose, smoking, body mass index, antiplatelet/anticoagulant, Geriatric Depression Scale, and, finally, for the other MRI markers.
For all the models, measures of association were expressed with the corresponding 95% confidence intervals. To examine the robustness of the associations, CMBs were included in these models as (a) per CMB increase and (b) multiple (Z2) versus none/single (< 2) CMB and (c) multiple categories of CMBs (0, 1, or Z2). P-values <0.05 were considered statistically significant. In view of the multiple tests performed on the specific cognitive domains (7 domains), we also used the Bonferroni correction to obtain an adjusted significance level for each domain-specific test: 0.05/7 = 0.007. These analyses were performed using standard statistical software (Statistical Package for Social Science, SPSS V20, SPSS Inc.).
RESULTS
A total of 1538 Chinese subjects participated in phase I of the EDIS Study, of whom 612 were screen positive and thus were invited for the second phase. Out of 612 screenpositive participants, 300 subjects agreed to participate in phase II. Of these 300 participants, 18 subjects had MRI scans that could not be graded. Table 1 shows the baseline characteristics of the subjects included in this analysis and those excluded. Of the remaining 282 subjects, 91 (32.3%) subjects had any CMBs. Among subjects with CMBs, 55 (60.4%) had a single CMB, 19 (20.8%) had 2 CMBs, and 17 (18.7%) >2 CMBs. Lobar CMBs were present in 75 (82.4%), of which 36 (39.6%) were cortical CMBs. The range of CMB counts was 0 to 43. Baseline characteristics of the participants with and without CMB are shown in Table 2 . Subjects with CMB more often used antiplatelets and anticoagulants and had more lacunes and a higher WML volume compared with those without CMBs. Increasing age was associated with higher prevalence of CMBs: among persons aged 60 to 64 years the prevalence was 28.6% increasing to 35.7% in those older than 75 years. With respect to other MRI markers, the most consistent associations were found between CMBs and lacunes, which were independent even after adjusting for WML and total brain volumes. For WML, only the model, which included CMBs as "a one lesion increase," suggested an association with WML volume: 0.05 (95% confidence interval, 0.01; 0.09; Table 3 ). However, this was not supported by the categorized analysis. Finally, CMBs were not associated with total brain volume.
With respect to cognition, Table 4 shows that there was an association between CMB and global composite Z-score [difference in the mean Z-score per CMB increase: À 0.06 (À0.11; À0.01)]. Furthermore, these associations were independent of other cardiovascular risk factors and other markers of cerebral small vessel disease. Also, the associations remained unaltered even after including number of years of education instead of dichotomizing education. The findings were further supported when CMBs were categorized as (a) either multiple versus none/single or (b) 0, 1, or Z2. In particular, the analyses using multiple categories show that the effect of CMBs on cognition was largely driven by the presence of at least 2 CMBs and are not evident for those who have 1 CMB.
As we found a significant association with the global composite Z-score, further analyses were conducted with domain-specific Z-scores (Table 5 ). In the fully adjusted models, CMBs were associated with executive function, attention, and visuoconstruction. Similar associations were observed when different categorizations of CMBs were used. Finally, when applying Bonferroni-corrected significance level of 0.007 to the domain-specific analyses, only the association with visuoconstruction reached this revised level of significance.
DISCUSSION
In this study of an elderly Chinese population, we showed that the presence and number of CMBs, especially the presence of 2 or more lesions, were-independent of other markers of cerebral small vessel disease-associated with poorer cognitive function.
There is a considerable debate about the exact role of CMBs in the pathophysiology of cognitive impairment and dementia. A recent systemic review and meta-analysis reported an association between CMBs and cognitive impairment. 26 Furthermore, the RUN DMC Study examining nondemented subjects (50 to 85 y) with cerebral small vessel disease also reported significant associations of the presence and number of CMBs with global cognitive function, as measured by the Cognitive Index, psychomotor speed and attention, though no association was found with the MMSE. 9 In contrast, data from the Rotterdam Study (n = 3979) has suggested that the number of CMBs, especially the presence of 5 or more CMBs, is associated with several nonmemory-related cognitive domains independent of other imaging markers of cerebral small vessel disease, suggesting an independent role for microbleed-associated vasculopathy in cognitive impairment. 10 In contrast, several other studies in whites have failed to find an independent association between CMB and cognitive decline. 27, 28 Finally, a clinic-based study among subjects with Alzheimer disease (mean age, 68 ± 9 y) showed that the presence and number of CMB was neither associated with baseline MMSE, nor with the change in MMSE over a period of 3 years. 29 With respect to Asian populations, thus far 2 Asian studies have shown an association of CMB with lower scores on MMSE. 16, 17 However, these studies lacked detailed neuropsychological assessment, utilized low-resolution MRI scans and other cerebrovascular diseases (strokes and WML) were not taken into consideration. With respect to the Chinese population, ours is the first study to suggest that CMBs are associated with cognitive function independent of other markers of cerebral small vessel disease. To examine the robustness of our findings, we also examined these associations using a different categorization (Z2 vs. <2 and multiple categories), apart from the "per CMB increase" analyses. This categorization further supported our original findings.
In relation to MRI markers of cerebrovascular disease, previous studies have reported an association of CMBs with silent brain infarcts, lacunar infarcts, and WMLs. 14, 30, 31 Our observations confirm the association of zAdjusted for age, sex, education, mean arterial blood pressure, cholesterol, random blood glucose, smoking, body mass index, antiplatelets/ anticoagulants, Geriatric Depression Scale, and other MRI markers (lacunes, WML, and total brain volumes).
Bold values represent statistically significant associations at P < 0.05. CI indicates confidence interval; CMB, cerebral microbleed; MRI, magnetic resonance imaging; WML, white matter lesion. cerebral CMBs with other markers of cerebral small vessel disease, including lacunes and-less clearly-WML. Some methodological issues need to be discussed. First, only half of the screen-positive subjects took part in phase II of the study, as described previously. 19 Briefly, subjects excluded from these analyses were older, had lower education and socioeconomic status, higher blood pressures, and lower cholesterol levels. This might have led to an underestimation of the prevalence of CMBs on MRI and subjects with poorer cognitive function and subsequently attenuation of the effect sizes. Despite this underestimation, we still found an association with the composite and several domain-specific Z-scores. Second, we did not have sufficient number of CMBs to specifically examine the association between location of CMBs (such as lobar region) and cognition. Third, due to the cross-sectional design of our study the temporal relationship between the presence of CMBs and the development of cognitive decline cannot be assessed. Fourth, due to the small number of dementia cases (n = 5) in this sample, we were unable to determine the effect of CMBs on clinically defined dementia. Fifth, even after adjusting for MRI markers such as WML, lacunes, and total brain volume, we cannot exclude the possibility of residual confounding by other effects of small vessel disease not fully captured by the current MRI markers. Sixth, the relatively small number of subjects with multiple CMBs (n = 36 with Z2 lesions) among the wide range of CMB count (0 to 43) in our population could have disproportionately affected the "per lesion" analyses, particularly in case of the domain-specific analyses. Finally, although we found several significant associations at a nominal significance level of 0.05 for several specific domains, after applying Bonferroni correction only the association with visuoconstruction reached the revised significance level of 0.007. Due to our small sample size the current study was probably underpowered to examine the large number of specific cognitive domains separately.
The strengths of this study include: utilization of a validated comprehensive neuropsychological test battery for the evaluation of cognitive function and a multimodal MRI (3 T) to visualize CMBs and other markers of cerebral small vessel disease. Furthermore, quantitative MRI markers, such as WML and total brain volume were utilized and adjusted for in our analysis.
In this study among Chinese subjects, CMBs were, independent of other concomitant markers of cerebral small vessel disease, associated with poorer cognitive function. Future studies with a prospective design are required to further elucidate the exact role of this novel marker of cerebral small vessel disease in the pathophysiology of cognitive impairment and dementia.
